Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thompson, K. L.
Right arrow Articles by Sistare, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, K. L.
Right arrow Articles by Sistare, F. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 57, 43-53 (2000)
Copyright © 2000 by the Society of Toxicology

Carcinogenicity

Evaluation of in Vitro Reporter Gene Induction Assays for Use in a Rapid Prescreen for Compound Selection to Test Specificity in the Tg.AC Mouse Short-Term Carcinogenicity Assay

Karol L. Thompson*, Barry A. Rosenzweig*, Yi Tsong{dagger} and Frank D. Sistare*,1

* Division of Applied Pharmacology Research, OTR/OPS, and {dagger} Office of Biostatistics, ORM, Center for Drug Evaluation and Research, Food & Drug Administration, Laurel, Maryland 20708

Under ICH guidelines, short-term carcinogenicity assays such as the Tg.AC assay are allowed alternatives for one species in the 2-year rodent bioassay. The Tg.AC transgenic mouse, which carries the v-Ha-ras oncogene under control of the {zeta}-globin promoter, develops skin papillomas in response to dermal application of carcinogens and tumor promoters. The appropriate specificity of the Tg.AC model for testing pharmaceuticals has not been systematically evaluated. The selection of candidate test compounds among noncarcinogenic pharmaceuticals would be aided by a high-throughput in vitro prescreen correlative of activity in the in vivo Tg.AC assay. Here we describe the development of a prescreen based on correct response to 24 compounds tested previously in Tg.AC mice. The in vitro prescreens, chosen to reflect molecular pathways possibly involved in Tg.AC papilloma formation, consisted of a {zeta}-globin promoter-luciferase construct stably expressed in K562 cells (Zeta-Luc) and three of the stress-response element–chloramphenicol acetyltransferase (CAT) fusion constructs stably expressed in HepG2 cells that are part of the CAT-Tox (L)iver assay. The stress response elements chosen were the c-fos promoter, the gadd153 promoter, and p53 response element repeats. Of the four assays, the gadd153-CAT assay showed the strongest concordance with activity in the Tg.AC assay, correctly classifying 78% of Tg.AC positive and 83% of Tg.AC negative compounds. The correlation was further improved by adding the Zeta-Luc assay as a second-stage screen. These cell-based assays will be used in a novel approach to selecting candidate compounds that challenge the specificity of the Tg.AC assay toward pharmaceuticals.

Key Words: stress response genes; Tg.AC; in vitro assay; gadd153; c-fos; zeta-globin; p53; K562; HepG2.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol SciHome page
K. L. Thompson and F. D. Sistare
Selection of Drugs to Test the Specificity of the Tg.AC Assay by Screening for Induction of the gadd153 Promoter in Vitro
Toxicol. Sci., August 1, 2003; 74(2): 260 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. L. Thompson, B. A. Rosenzweig, J. L. Weaver, J. Zhang, K. K. Lin, and F. D. Sistare
Evaluation of the Tg.AC Assay: Specificity Testing with Three Noncarcinogenic Pharmaceuticals that Induce Selected Stress Gene Promoters in Vitro and the Inhibitory Effects of Solvent Components
Toxicol. Sci., August 1, 2003; 74(2): 271 - 278.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. E. Cannon
The Tg.AC Mouse Model Passes Test by Failing to Respond
Toxicol. Sci., August 1, 2003; 74(2): 233 - 234.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
F. D. Sistare, K. L. Thompson, R. Honchel, and J. DeGeorge
Evaluation of the Tg.AC Transgenic Mouse Assay for Testing the Human Carcinogenic Potential of Pharmaceuticals--Practical Pointers, Mechanistic Clues, and New Questions
International Journal of Toxicology, January 1, 2002; 21(1): 65 - 79.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.